SCOLARI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 18.504
EU - Europa 16.004
AS - Asia 12.346
SA - Sud America 2.984
AF - Africa 214
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 26
Totale 50.141
Nazione #
US - Stati Uniti d'America 18.208
PL - Polonia 5.834
CN - Cina 4.030
SG - Singapore 3.751
UA - Ucraina 3.590
BR - Brasile 2.546
IT - Italia 2.200
HK - Hong Kong 1.986
DE - Germania 1.375
VN - Vietnam 965
FI - Finlandia 803
TR - Turchia 555
IE - Irlanda 494
GB - Regno Unito 472
RU - Federazione Russa 470
FR - Francia 296
IN - India 192
AR - Argentina 191
JP - Giappone 156
CA - Canada 150
ID - Indonesia 148
BD - Bangladesh 142
NL - Olanda 131
MX - Messico 97
IQ - Iraq 89
SE - Svezia 72
EC - Ecuador 71
ZA - Sudafrica 68
AU - Australia 61
CO - Colombia 49
AT - Austria 47
PK - Pakistan 44
MA - Marocco 43
ES - Italia 35
CZ - Repubblica Ceca 34
PY - Paraguay 34
SA - Arabia Saudita 32
UZ - Uzbekistan 28
VE - Venezuela 27
EG - Egitto 25
EU - Europa 25
BE - Belgio 24
CL - Cile 23
IR - Iran 23
JO - Giordania 23
PE - Perù 22
CH - Svizzera 19
KE - Kenya 19
MY - Malesia 19
AZ - Azerbaigian 16
KZ - Kazakistan 15
LT - Lituania 15
TW - Taiwan 15
KR - Corea 13
UY - Uruguay 13
LV - Lettonia 12
NP - Nepal 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
AL - Albania 10
ET - Etiopia 10
RO - Romania 10
TN - Tunisia 10
KG - Kirghizistan 9
PA - Panama 9
DZ - Algeria 8
MU - Mauritius 8
PS - Palestinian Territory 8
TH - Thailandia 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
HU - Ungheria 7
OM - Oman 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
AM - Armenia 6
BG - Bulgaria 6
LB - Libano 6
PH - Filippine 6
RS - Serbia 6
GR - Grecia 5
HN - Honduras 5
JM - Giamaica 5
MK - Macedonia 5
BW - Botswana 4
CR - Costa Rica 4
GT - Guatemala 4
KW - Kuwait 4
LU - Lussemburgo 4
NO - Norvegia 4
UG - Uganda 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
HR - Croazia 3
KH - Cambogia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
Totale 50.106
Città #
Warsaw 5.815
Jacksonville 2.272
Fairfield 2.014
Woodbridge 1.999
Hong Kong 1.966
Singapore 1.807
Ashburn 1.194
Houston 1.180
Princeton 970
Ann Arbor 928
Cambridge 869
Beijing 808
Wilmington 770
Seattle 749
Nanjing 726
Dublin 487
Istanbul 442
Chandler 401
Los Angeles 335
Helsinki 323
Ho Chi Minh City 296
Nanchang 295
New York 287
The Dalles 261
Milan 249
Des Moines 237
Dong Ket 216
Buffalo 205
Moscow 199
São Paulo 197
Redondo Beach 185
Changsha 184
Shenyang 177
Hebei 176
Brescia 159
Dearborn 127
Munich 127
Hanoi 126
San Diego 115
Tianjin 115
Jiaxing 109
Dallas 97
Rio de Janeiro 93
Shanghai 93
Hangzhou 91
Jinan 90
Chicago 85
Verona 78
Rome 77
San Francisco 76
Phoenix 75
Jakarta 72
Toronto 61
Kocaeli 60
Kunming 57
Tokyo 57
London 55
Nuremberg 54
Brooklyn 48
Belo Horizonte 46
Santa Clara 46
Montreal 42
Lanzhou 41
Brasília 40
Guangzhou 40
Ningbo 38
Turku 35
Zhengzhou 35
Redwood City 34
Curitiba 33
Melbourne 33
Porto Alegre 32
Baghdad 30
Campinas 30
Norwalk 30
Council Bluffs 29
Atlanta 28
Dhaka 28
San Mateo 28
Brno 26
Da Nang 26
Palermo 26
Augusta 25
Haiphong 25
Vienna 25
Johannesburg 24
Taizhou 24
Tashkent 24
Amman 23
Boston 23
Denver 23
Frankfurt am Main 23
Bologna 22
Düsseldorf 22
Erbil 22
Guarulhos 22
Quito 22
Washington 22
Biên Hòa 21
Chennai 21
Totale 32.605
Nome #
Trattamento del linfocele postoperatorio mediante instillazione su guida ecografica di polivinil-pirrolidone iodico. Casistica personale. 871
The pathophysiology of IgA nephropathy 574
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 395
Genome-wide association study identifies susceptibility loci for IgA nephropathy 368
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway 275
Genetic drivers of kidney defects in the digeorge syndrome 270
The copy number variation landscape of congenital anomalies of the kidney and urinary tract. 257
Insufficienza renale acuta e o subacuta richiedente dialisi in corso di malattia ateroembolica renale: impatto sulla sopravvivenza del paziente e del rene. 256
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 255
Suprarenal aortic cross-clamping in the elective surgery of abdominal aortic aneurysms. Lessons from 68 cases out of consecutive survey of 746 abdominal aortic substitutions. 248
Lack of association between dialysis modality and outcomes in atheroembolic renal disease 235
Autoimmunity in membranous nephropathy targets aldose reductase and SOD2 230
PREDICTORS OF RENAL AND PATIENT OUTCOMES IN ATHEROEMBOLIC RENAL DISEASE: A PROSPECTIVE STUDY. 229
Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study 229
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. 228
A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. 228
The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. 225
Malattia cistica della midollare (MCKD), Nefropatia iperuricemica familiare giovanile (FJHN) e Glomerulocisti (GCKD) sono causate da mutazioni dello stesso gene (UMOD) che determinano alterazioni del trasporto cellulare di uromodulina. 225
The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia. 224
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin 222
Uromodulin storage diseases: clinical aspects and mechanisms. 222
Defective intracellular trafficking of uromodulin mutant isoforms 222
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 220
The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. 219
Genetic studies of IgA nephropathy: past, present, and future. 218
Coexistence of Different Circulating Anti-PodocyteAntibodies in Membranous Nephropathy 217
Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. 216
Autosomal Dominant tubulointerstitial Kidney Disease with Adult onset due to a novel Renin Mutation Mapping in the Mature protein 216
Mutations in DSTYK and dominant urinary tract malformations. 214
IgA nephropathy: the presence of familial disease does not confer an increased risk for progression 213
Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. 213
CHOLESTEROL CRYSTAL EMBOLISM: A RECOGNIZABLE CAUSE OF RENAL DISEASE 212
IgA nephropathy--the case for a genetic basis becomes stronger. 212
Genetic approaches to human renal agenesis/hypoplasia and dysplasia. 210
Infertility and hypergonadotropic hypogonadism as first evidence of hereditary apolipoprotein A-I amyloidosis 210
Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. 210
Familial vesicoureteral reflux: testing replication of linkage in seven new multigenerational kindreds 210
Urinary secretion and extracellular aggregation of mutant uromodulin isoforms 205
Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3 205
Localization of a gene for nonsyndromic renal hypodysplasia to chromosome 1p32-33. 203
Renal outcome in patients with congenital anomalies of the kidney and urinary tract. 203
Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families 203
Atheroembolic renal disease 202
Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis 202
Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. 200
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23 198
Copy number disorders are a Common Cause of Congenital Kidney Malformations 196
Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection. 194
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial. 193
Phenotypic expansion of DGKE-associated diseases. 192
The Case ∣ Familial occurrence of retinitis pigmentosa, deafness, and nephropathy. 191
Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases 191
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 184
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 183
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 174
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 173
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model 172
The progression from obesity to type 2 diabetes in Alström syndrome. 169
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 166
LES FORMES FAMILIALES DE NÉPHROPATHIE À IgA ÉTUDES CLINIQUE ET GÉNÉTIQUE 166
Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans 165
AUTOSOMAL DOMINANT MEDULLARY CYSTIC KIDNEY DISEASE 165
Uromodulin: from monogenic to multifactorial diseases. 165
Anemia emolitica autoimmune acquisita (AEAA) da incompatibilità minore ABO: un raro esempio di graft versus host disease (GVHD) in corso di trapianto di rene (TX). 164
ORO-FACIO-DIGITAL SYNDROME 163
Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. 160
Berger's Disease 157
IDENTIFICATION OF A NEW LOCUS FOR MEDULLARY CYSTIC DISEASE ON CHROMOSOME 16 154
A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease 151
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 148
Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. 147
Non-collagen genes role in digenic Alport syndrome 147
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 146
A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies. 144
Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure. 143
Familial IgM mesangial nephropathy: a morphologic and immunogenetic study of three pedigrees. 142
The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors 141
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 140
La sindrome oro-facio-digitale tipo 1: una causa infrequente di malattia cistica renale a carattere ereditario. 135
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection 135
Early histopathologic changes predicting long-term kidney transplant survival. 134
Clustering familiare di differenti forme di glomerulonefrite primitiva: studio Valtrompia: 134
Immunogenetics of Henoch-Schoenlein disease. 131
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 130
Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. 130
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. 130
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes 130
Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. 128
Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids. 127
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. 127
Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. 126
Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome 125
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens. 125
Spermatogenic and steroidogenic impairment of the testicle characterizes the hereditary leucine-75-proline apolipoprotein a-I amyloidosis. 124
The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait 124
Medullary cystic kidney disease: past and present. 124
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? 124
Utilità della scintigrafia con 99mTC solofo-colloide nella diagnosi di rigetto del rene trapiantato. 124
Atheroembolic renal disease. 124
Liver disease in renal transplant patients treated with azathioprine or ciclosporin. 123
Totale 19.619
Categoria #
all - tutte 227.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.033 0 0 0 0 0 1.086 292 967 1.003 680 674 331
2021/20223.095 134 746 27 101 55 94 171 202 172 339 284 770
2022/20231.966 518 20 32 102 118 644 6 146 193 17 89 81
2023/20242.787 104 49 153 244 77 274 122 80 1.022 45 63 554
2024/20257.332 48 46 53 839 965 576 996 200 721 386 1.588 914
2025/20269.083 1.275 2.311 1.457 2.628 1.215 197 0 0 0 0 0 0
Totale 50.693